AMWC Monaco is where ground breaking discoveries in the medical aesthetics field are first revealed. Among this year’s breakthrough is a hair regrowth system powered by Calecim’s cell-messaging technology. The active ingredient, called PTT-6, is derived from ethically sourced stem cells, and is a powerful complex of exosomes, growth factors and proteins.
PTT-6 works by stimulating dormant hair follicles, dramatically reducing inflammation, and increasing follicle cell production. Treatment can be administered both in professional settings and at home, thereby improving patient compliance and ensuring reliable outcomes.
Calecim’s Advanced Hair System has been highlighted in peer-reviewed journals for its effectiveness in treating both male and female pattern baldness, as well as telogen effluvium, including post-COVID hair shedding.
A presentation by Dr Manav Bawa (Time Clinic) at AMWC, highlighted how PTT-6 could be revolutionary for mild to moderate hair loss, providing rapid, consistent, and side-effect-free results in just 6 to 12 weeks. Dr. Bawa shared his own clinical findings on the PTT-6 treatment for menopausal hair loss, a patient demographic that has often been overlooked.
Hair loss can profoundly affect women's self-esteem and overall quality of life. The preliminary results of Dr. Bawa's study indicate that PTT-6 can effectively reverse hair shedding, improving the patient’s overall wellbeing.
One patient, amazed by her progress, said, "Six weeks and the results are incredible. I thought, with perimenopause, that I was going bald and would be for life. I was so self-conscious, and now I feel like my hair will indeed go back to how it used to be. I am so, so happy."
Says Dr Bawa, “PTT-6 gives hope to those suffering from hair loss, enabling them to regain their confidence as they embark on a hair regrowth journey that is backed by science and results.”
FUTHER INFORMATION
Calecim
E: professionalservices@calecim.com
